Caredx, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
Baron Capital Group, along with its affiliates, has reported an amendment to its Schedule 13G filing, indicating a change in its beneficial ownership of CareDx, Inc. common stock.
NASDAQ
Gagnon Securities LLC, Gagnon Advisors, LLC, and Neil Gagnon have updated their beneficial ownership filings for CareDx, Inc., reporting a combined stake.
NASDAQ
State Street Corporation has disclosed beneficial ownership of 4.8% of CareDx Inc.'s common stock as of June 30, 2026.
NASDAQ
The Vanguard Group reported a 0% beneficial ownership in CareDx Inc. following an internal realignment that disaggregates its reporting.
NASDAQ
Neil Gagnon and affiliated entities, Gagnon Securities LLC and Gagnon Advisors, LLC, report a combined beneficial ownership of 5.9% in CareDx, Inc. common stock.
NASDAQ
State Street Corporation has reported a 5.3% beneficial ownership stake in CareDx Inc., holding over 2.7 million shares.
NASDAQ
Baron Capital Group, Inc., Ronald Baron, and affiliated entities have reported a combined beneficial ownership of 5.93% in CareDx, Inc. common stock as of September 30, 2025.
NASDAQ
The Vanguard Group has increased its beneficial ownership in CareDx Inc to 7.04% of common stock as of September 30, 2025.
NASDAQ
Neil Gagnon, along with Gagnon Securities LLC and Gagnon Advisors, LLC, has reported a combined beneficial ownership of 5.2% in CareDx, Inc. common stock.
NASDAQ
BlackRock, Inc. has filed an amended Schedule 13G, confirming its continued beneficial ownership of 8.0% of CareDx Inc.'s common stock as of March 31, 2025.
NASDAQ
ARK Investment Management LLC has filed an amended Schedule 13G, reporting a 4.49% beneficial ownership stake in CareDx, Inc. as of December 31, 2024.
NASDAQ
The Vanguard Group has filed an amended Schedule 13G, reporting a 9.06% beneficial ownership stake in CareDx Inc. as of December 31, 2024.
NASDAQ
ARK Investment Management LLC has disclosed a 5.67% beneficial ownership stake in CareDx, Inc., holding 2,988,597 shares of common stock as of September 30, 2024.